MSB 10.4% $1.49 mesoblast limited

Overwhelming efficacy - the stats required, page-9

  1. 119 Posts.
    lightbulb Created with Sketch. 14
    Great analysis @kervio , thank you!

    I wonder if they will work with a minimum of 30% completion for first readout but pool every bit of data they can. Im guessing (hoping) they will have data on more than 90 patients so hopefully we might be looking at closer to 40-50% completed at least for that first look.



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.